Gene expression markers of Tumor Infiltrating Leukocytes
暂无分享,去创建一个
Patrick Danaher | Steven P. Fling | Andrew B. White | Sarah Warren | Joseph Beechem | Kunle Odunsi | Lucas Dennis | Melissa A. Geller | P. Danaher | L. Dennis | J. Beechem | K. Odunsi | S. Fling | Leonard D'Amico | M. Geller | M. Disis | S. Warren | Mary L. Disis | Leonard D’Amico | Andrew White
[1] E John Wherry,et al. T cell exhaustion , 2011 .
[2] H. Muller-Hermelink,et al. The serine protease granzyme M is preferentially expressed in NK-cell, gamma delta T-cell, and intestinal T-cell lymphomas: evidence of origin from lymphocytes involved in innate immunity. , 2003, Blood.
[3] Burton E. Barnett,et al. Cutting Edge: B Cell–Intrinsic T-bet Expression Is Required To Control Chronic Viral Infection , 2016, The Journal of Immunology.
[4] P. Klenerman,et al. CD39 Expression Identifies Terminally Exhausted CD8+ T Cells , 2015, PLoS pathogens.
[5] F. Speleman,et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.
[6] J. Schlom,et al. Tumor-infiltrating immune cells and prognosis: the potential link between conventional cancer therapy and immunity , 2011, Experimental biology and medicine.
[7] Dimitris Anastassiou,et al. Biomolecular Events in Cancer Revealed by Attractor Metagenes , 2012, PLoS Comput. Biol..
[8] C. Sander,et al. The landscape of T cell infiltration in human cancer and its association with antigen presenting gene expression , 2015, bioRxiv.
[9] Z. Trajanoski,et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. , 2013, Immunity.
[10] N. K. Sah,et al. Structural, functional and therapeutic biology of survivin. , 2006, Cancer letters.
[11] C. Sautès-Fridman,et al. The immune contexture in human tumours: impact on clinical outcome , 2012, Nature Reviews Cancer.
[12] Jing Zhu,et al. Apparently low reproducibility of true differential expression discoveries in microarray studies , 2008, Bioinform..
[13] T. Nielsen,et al. The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.
[14] Jérôme Galon,et al. The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures. , 2013, Immunity.
[15] E. Wherry,et al. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. , 2007, Immunity.
[16] Steve Horvath,et al. WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.
[17] F. Marincola,et al. Cancer classification using the Immunoscore: a worldwide task force , 2012, Journal of Translational Medicine.
[18] H. Masai,et al. Functions of mammalian Cdc7 kinase in initiation/monitoring of DNA replication and development. , 2003, Mutation research.
[19] P. Hugenholtz. Exploring prokaryotic diversity in the genomic era , 2002, Genome Biology.
[20] Pornpimol Charoentong,et al. Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy , 2015, Genome Biology.
[21] L. Chin,et al. Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade. , 2016, Cancer discovery.
[22] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[23] Homin K. Lee,et al. Coexpression analysis of human genes across many microarray data sets. , 2004, Genome research.
[24] J. Taube,et al. Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy , 2016, Nature Reviews Cancer.
[25] Ash A. Alizadeh,et al. Robust enumeration of cell subsets from tissue expression profiles , 2015, Nature Methods.
[26] R. Geha,et al. Adapter proteins SLP-76 and BLNK both are expressed by murine macrophages and are linked to signaling via Fcgamma receptors I and II/III. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[27] G. Parmigiani,et al. A statistical framework for expression‐based molecular classification in cancer , 2002 .
[28] Xiangshan Zhao,et al. Mitosin/CENP-F in mitosis, transcriptional control, and differentiation. , 2006, Journal of biomedical science.
[29] J. Reiffers,et al. Expression of Flt3-ligand by the endothelial cell , 2000, Leukemia.
[30] Ash A. Alizadeh,et al. Abstract PR09: The prognostic landscape of genes and infiltrating immune cells across human cancers , 2015 .
[31] D. Chaussabel,et al. The Relationship of Immune Cell Signatures to Patient Survival Varies within and between Tumor Types , 2015, PloS one.